“Imagine a world where you never lose your luggage,” says CEO of Bluesmart, Diego Saez-Gil. He motions to a compact carry-on suitcase sitting beside us and tells me he can track this piece of luggage anywhere.
Saez-Gil’s Y Combinator-backed startup makes these hardshell suitcases. It can locate, lock and weigh your belongings from an app on your smartphone.
Like many inventors, Thomas Edison started out as a teenage tinkerer with empty pockets. But his work on improving the telegraph led him to a better stock market ticker and a valuable patent, which he sold for $10,000 to Western Union. He used the money to build a lab in Menlo Park, N.J., and amp up his work with electricity, which attracted venture investments from J.P. Morgan and William Henry Vanderbilt and, eventually, led to GE.
Faced with diminishing returns on R&D investments, large pharmaceutical companies are searching for innovative ways to successfully identify, develop, and market products with financial viability. Yet small discovery companies and biotechs continue to outpace large pharma in the approval of NMEs (new molecular entities).
These smaller companies seem more able to adapt and adopt new technologies nimbly to meet changing landscapes. Janssen Pharmaceuticals is meeting the challenge by adopting a small venture discovery model, the Janssen Incubator (JI).
Cada seis minutos se produce un caso de ictus en España, que mata a 40.000 españoles al año según la Federación Española de Ictus. A nivel global, se producen 15 millones de casos anuales, de los que 5 son fatales y otros 5 causan discapacidad permanente. Para evitarlo, la detección rápida de un posible ataque es fundamental para salvar vidas y disminuir las secuelas.
“IBM is now hours away from Dow infamy,” said Andrew Ross Sorkin on NBC Squawk Box this morning. “IBM is on track for the second consecutive year as the very worst performer in the Dow Jones Industrial Index for the second year in a row. That’s the first time that has happened since 1995.” In 2014, IBM lost 15 percent of its market cap. Despite having the largest stock of patents in a booming IT sector, IBM lost even more value than ExxonMobil [XOM] which is having to cope with collapsing oil prices.
The Drucker Forum 2014 last week in Vienna, Austria, was an exhilarating and uplifting mix of leading speakers, blinding insights, moving moments, frank interchanges, thoughtful explorations, genuine learning and elegant entertainment, with only occasional hints of cliché or snake oil.
Water scarcity affects every corner of the globe. Around 1.2 billion people — almost 20 percent of Earth’s population — lives with the constant worry of not having enough drinking water to survive, according to the United Nations.
However, almost three-quarters of this world we inhabit is covered in water, the vast majority of which is undrinkable salt water. And it’s this problem that a crack team of innovators in London is looking to solve.
These smaller companies seem more able to adapt and adopt new technologies nimbly to meet changing landscapes. Janssen Pharmaceuticals is meeting the challenge by adopting a small venture discovery model, the Janssen Incubator (JI).
